DelveInsight’s Spinal Cord Stimulators Market Insights report provides current and forecast market analysis, the market shares of leading spinal cord stimulators companies, challenges, drivers, barriers, trends, and key companies in the market.
Key Takeaways from the Spinal Cord Stimulators Market Report
• The global spinal cord stimulation market was valued at USD 2.25 billion in 2023 and is projected to reach USD 3.72 billion by 2032, growing at a CAGR of ~8.70% during the forecast period.
• As per DelveInsight estimates, North America is anticipated to dominate the global spinal cord stimulators market during the forecast period.
• Notable spinal cord stimulators companies such as Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical, and several others are currently operating in the spinal cord stimulators market.
• In January 2025, Saluda Medical, Inc. announced FDA approval for its biomarker-based, automated patient programming platform, EVA™, in spinal cord stimulation (SCS). This platform represents a significant advancement in SCS therapy and is compatible with all commercially implanted Evoke® System patients in the U.S.
• In December 2024, ONWARD Medical N.V. received FDA de novo classification and marketing authorization for its ARC-EX System, a non-invasive spinal cord stimulation device. Unlike traditional systems, the ARC-EX delivers targeted electrical stimulation through the skin via electrodes placed on the neck, eliminating the need for surgery. This advancement marks a significant step forward in the spinal cord stimulation market, offering a less invasive option for individuals with spinal cord injury (SCI).
• In September 2024, Nevro Corp., a leading global medical device company focused on delivering transformative solutions for chronic pain management, announced the FDA approval and limited market release of the HFX iQ™ system, featuring HFX AdaptivAI™. This advanced, responsive pain management platform enhances the HFX iQ spinal cord stimulation (SCS) system.
• IIn April 2024, Medtronic received FDA approval for its Inceptiv closed-loop spinal cord stimulator (SCS) designed to treat chronic pain. This approval adds a cutting-edge solution to the spinal cord stimulation market, enhancing personalized pain management through real-time adjustments based on patient feedback.
• In May 2022, Medtronic announced the launch of CareGuidePro, a new mobile application and web portal that serves as a virtual guide for patients throughout their spinal cord stimulation therapy journey.
To read more about the latest highlights related to the spinal cord stimulators market, get a snapshot of the key highlights entailed in the Global Spinal Cord Stimulators Market Report
Spinal Cord Stimulators Overview
Spinal cord stimulators (SCS) are medical devices used to manage chronic pain, particularly in patients with conditions such as chronic lower back pain, neuropathic pain, and failed back surgery syndrome. These devices deliver electrical impulses to the spinal cord through implanted electrodes, altering pain signals before they reach the brain, providing relief for patients who have not responded to conventional treatments. Spinal cord stimulators are particularly beneficial for patients with conditions like spinal cord injuries, herniated discs, and post-surgical pain. With continuous advancements in technology, including closed-loop systems and non-invasive models, the spinal cord stimulation market is expanding rapidly. Despite their efficacy, the high cost and potential risks associated with implantation can pose challenges, but the increasing prevalence of chronic pain conditions and growing adoption of spinal cord stimulators are expected to drive the market’s growth.
Spinal Cord Stimulators Market Insights
North America is expected to lead the spinal cord stimulators market during the forecast period, driven by the rising prevalence of lower back pain, spinal degenerative disc diseases, and related conditions. The United States, in particular, represents the largest market, supported by a growing number of patients experiencing chronic pain. This growth is further fueled by the launch of new products and strategic commercial agreements by key manufacturers in the spinal cord stimulator industry. For example, the introduction of Boston Scientific’s WaveWriter Alpha portfolio and Abbott’s FDA-approved Proclaim™ Plus spinal cord stimulation system featuring FlexBurst360™ therapy are expected to significantly boost the market. These factors, along with the increasing demand for effective pain management solutions, are poised to drive the growth of the spinal cord stimulators market in North America.
To know more about why North America is leading the market growth in the spinal cord stimulators market, get a snapshot of the Spinal Cord Stimulators Market Outlook
Spinal Cord Stimulators Market Dynamics
The increasing prevalence of chronic lower back pain (LBP) and neuropathic pain, often caused by injuries and trauma, is expected to drive the growth of the spinal cord stimulation market. LBP is one of the most common causes of disability worldwide, with a significant portion of patients suffering from failed back surgeries. Additionally, the rising incidence of traumatic injuries, such as those from road accidents and falls, which can lead to spinal cord injuries and related conditions, further amplifies the demand for spinal cord stimulators. Advancements in spinal cord stimulation technologies, like the development of innovative therapies for chronic pain treatment, are also contributing to market growth. However, challenges such as device-related risks and high costs could impact the overall growth of the spinal cord stimulators market.
Get a sneak peek at the spinal cord stimulators market dynamics @ https://www.delveinsight.com/report-store/spinal-cord-stimulator-market
Coverage: Global
Study Period: 2022 to 2032
Spinal Cord Stimulators Market CAGR: ~8.70%
Key Spinal Cord Stimulators Companies: Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., , and others.
Spinal Cord Stimulators Market Segmentation
Market Segmentation By Product Type: Rechargeable, Non-Rechargeable, others.
Market Segmentation By Application: Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), others.
Market Segmentation By End User: Hospitals, Clinics, Ambulatory Surgical Centers.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the spinal cord stimulators market are set to emerge as the trendsetter, explore @ Spinal Cord Stimulators Companies
Table of Contents
1. Electrophysiology Devices Market Report Introduction
2. Electrophysiology Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Electrophysiology Devices Market Key Factors Analysis
6. Electrophysiology Devices Market Porter’s Five Forces Analysis
7. Electrophysiology Devices Market Layout
8. Electrophysiology Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
Media ContactCompany Name: DelveInsightContact Person: Jatin VimalEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/
